In conclusion, the present study suggests that miR-25-3p-mediated SIK1/CRTC2/CREB1 and TWIST1/PI3K/Akt/GSK3β signaling pathways could be potential therapeutic targets for future antipsychotic drugs and candidate diagnosis biomarkers of schizophrenia. The gene discussed is AKT1; the disease is schizophrenia.